Pfizer received full approval in the U.S. on Thursday for its COVID-19 pill Paxlovid that's been the go-to treatment against the coronavirus.
More than 11 million prescriptions for Paxlovid have been dispensed since the U.S. Food and Drug Administration allowed emergency use in late 2021. The emergency status was based on early studies and was intended to be temporary pending follow-up research.
The decision allows Pfizer's drug to remain on the market indefinitely and to be marketed similarly to other drugs.The U.S. government has stockpiled millions of doses of Paxlovid and patients will continue to receive it at no charge, the FDA said in a statement. More than 14,000 new COVID-19 cases were reported each week last month, although most U.S. cases are no longer reported to health authorities.
Pfizer originally studied Paxlovid in the highest-risk COVID-19 patients: unvaccinated adults with other health problems and no evidence of prior coronavirus infection. In that group, the FDA said the drug lowered the risk of hospitalization or death by 86 per cent when given shortly after symptoms emerged.
In more recent studies of people who have had COVID-19, Paxlovid still significantly decreased the chance of hospitalization or death by more than 85 per cent.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Elon Musk’s Neuralink gets U.S. FDA approval for human clinical study of brain implantsElon Musk’s Neuralink receives U.S. Food and Drug Administration approval for brain implants company hopes will help paralyzed people walk, cure other neurological ailments
Read more »
New COVID modelling shows B.C. with the highest incidence of the virus in CanadaAccording to the ‘hazard index’ published by COVID-19 Resources Canada, B.C. has had the highest score across the country for more than a month
Read more »
U.S. study finds 1 in 10 get long COVID after Omicron, starts identifying key symptomsAbout 10 per cent of people appear to suffer long COVID after an Omicron infection, a lower estimate than earlier in the pandemic, according to a study of nearly 10,000 Americans that aims to help unravel the mysterious condition.
Read more »
Former Unifor head Jerry Dias will not be charged in alleged bribery casePolice began investigating Dias after the union handed over money he allegedly accepted from a supplier of COVID test kits he promoted
Read more »
THINKING OUT LOUD: Nursing homes post-pandemic | SaltWireHALIFAX, N.S. — COVID is still around but for practical purposes the public health emergency is over. And that is welcomed news for the Nursing Homes of ...
Read more »
B.C. company expands antibody research, production facilities for second timeVANCOUVER — A Vancouver-based company that helped develop the first antibody therapy treatment for COVID-19 is expanding its research and development capacity as it continues to pursue world-leading new medicines, says Innovation Minister Francois-Ph
Read more »